Deal could allow Amgen to “entrench the monopoly positions” of two Horizon medications, regulators say.
More Stories
IBD and MarketWatch’s fifth annual survey of the most trusted financial companies
Consumers have cast their votes for the financial services companies they trust the most
Stocks at risk of a bubble after Fed’s jumbo rate cut, BofA strategist says
One Bank of America strategist thinks the Federal Reserve’s decision to cut interest-rates by 50 basis points this week will...
A huge NASA contract has sent Intuitive Machines’ stock skyrocketing. This analyst sees even more upside.
Intuitive Machines is “the leading beneficiary of NASA’s lunar commercialization efforts,” says B. Riley Securities analyst Mike Crawford.
Oil on track for weekly gains after Fed rate cut, rising Middle East tensions
Oil futures were on track for solid weekly gains, boosted by the Federal Reserve’s large rate cut and a renewed...
FedEx’s earnings miss may be more of a speed bump than a brick wall, analyst says
Analysts sees a potential spinoff of FedEx’s freight business as a possible boost, but the stock is dropping sharply
If you’re not sure how to invest, it’s as easy as picking two funds.
Get peace of mind, plus a piece of the action